BELITE BIO INC - ADR (BLTE) Institutional Shareholders
BELITE BIO INC - ADR (BLTE) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $1.44B in BLTE holdings during the latest filing period.
Darwin Global Management, Ltd. is currently the largest disclosed institutional shareholder of BLTE tracked by InsiderSet, reporting ownership valued at approximately $456.59M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $520.70M, representing an estimated gain of +14.04% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 78% of the total disclosed BLTE value among the investors covered in this analysis. Major shareholders include Darwin Global Management, Ltd., Paradigm Biocapital Advisors Lp, Rtw Investments, Lp, and several other long-term asset managers with concentrated positions in BELITE BIO INC - ADR (BLTE).
This page ranks the largest institutional BLTE shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
78
Total Reported Value
$1.44B
Largest Holder
Darwin Global Management, Ltd.
Largest Position
$456.59M
Insider Transactions (90d)
40
Latest Filing Quarter
Q2 2026
New Institutional Positions
112
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Darwin Global Management, Ltd. | 12.14% | 3,077,219 | $456,588,244 | $520,696,227 | +$64,107,983 | +14.04% | |
| Paradigm Biocapital Advisors Lp | 3.55% | 1,232,877 | $189,844,565 | $208,615,117 | +$18,770,552 | +9.89% | |
| Rtw Investments, Lp | 0.94% | 715,332 | $110,150,398 | $121,041,328 | +$10,890,930 | +9.89% | |
| Millennium Management Llc | 0.05% | 494,564 | $76,155,438 | $83,685,174 | +$7,529,736 | +9.89% | |
| Maverick Capital Ltd | 0.55% | 396,311 | $61,025,949 | $67,059,784 | +$6,033,835 | +9.89% | |
| Eventide Asset Management, Llc | 0.80% | 390,829 | $60,181,804 | $66,132,175 | +$5,950,371 | +9.89% | |
| Deerfield Management Company, L.P. | 0.57% | 357,199 | $55,003,288 | $60,441,643 | +$5,438,355 | +9.89% | |
| Holocene Advisors, Lp | 0.09% | 251,035 | $38,655,624 | $42,477,632 | +$3,822,008 | +9.89% | |
| Logos Global Management Lp | 1.66% | 250,000 | $38,496,250 | $42,302,500 | +$3,806,250 | +9.89% | |
| Morgan Stanley | 0.00% | 235,071 | $36,197,407 | $39,776,364 | +$3,578,957 | +9.89% | |
| Ubs Group Ag | 0.01% | 224,989 | $34,644,931 | $38,070,389 | +$3,425,458 | +9.89% | |
| Citadel Advisors Llc | 0.02% | 186,168 | $28,667,080 | $31,501,487 | +$2,834,407 | +9.89% | |
| Goldman Sachs Group Inc | 0.00% | 166,188 | $25,590,459 | $28,120,671 | +$2,530,212 | +9.89% | |
| Affinity Asset Advisors, Llc | 1.24% | 165,000 | $25,407,525 | $27,919,650 | +$2,512,125 | +9.89% | |
| Mpm Bioimpact Llc | 1.29% | 137,208 | $21,127,974 | $23,216,966 | +$2,088,992 | +9.89% | |
| Bank Of America Corp | 0.00% | 124,783 | $19,214,710 | $21,114,531 | +$1,899,821 | +9.89% | |
| Patient Square Capital Lp | 2.62% | 110,000 | $16,938,350 | $18,613,100 | +$1,674,750 | +9.89% | |
| Duquesne Family Office Llc | Stanley Druckenmiller | 0.38% | 106,100 | $16,338,000 | $17,953,181 | +$1,615,181 | +9.89% |
| Price T Rowe Associates Inc | 0.00% | 105,859 | $16,301,000 | $17,912,401 | +$1,611,401 | +9.89% | |
| Jane Street Group, Llc | 0.01% | 65,801 | $10,132,367 | $11,134,187 | +$1,001,820 | +9.89% | |
| Bnp Paribas Financial Markets | 0.00% | 57,125 | $8,796,393 | $9,666,121 | +$869,728 | +9.89% | |
| Renaissance Technologies LLC | Jim Simons | 0.01% | 55,763 | $8,586,666 | $9,435,657 | +$848,991 | +9.89% |
| Point72 Asset Management, L.P. | 0.01% | 51,186 | $7,881,877 | $8,661,183 | +$779,306 | +9.89% | |
| Soleus Capital Management, L.P. | 0.27% | 50,524 | $7,779,938 | $8,549,166 | +$769,228 | +9.89% | |
| Trexquant Investment Lp | 0.05% | 49,516 | $7,624,721 | $8,378,602 | +$753,881 | +9.89% | |
| Two Sigma Investments, Lp | 0.00% | 38,100 | $5,866,829 | $6,446,901 | +$580,072 | +9.89% | |
| Pfm Health Sciences, Lp | 0.47% | 34,803 | $5,359,140 | $5,889,016 | +$529,876 | +9.89% | |
| Jpmorgan Chase & Co | 0.00% | 33,181 | $5,131,442 | $5,614,557 | +$483,115 | +9.41% | |
| Walleye Capital Llc | 0.02% | 31,721 | $4,884,558 | $5,367,510 | +$482,952 | +9.89% | |
| Artia Global Partners Lp | 0.73% | 24,989 | $3,847,931 | $4,228,389 | +$380,458 | +9.89% | |
| Geode Capital Management, Llc | 0.00% | 22,640 | $3,486,220 | $3,830,914 | +$344,694 | +9.89% | |
| Balance Capital Partners L.P. | 2.49% | 22,500 | $3,464,663 | $3,807,225 | +$342,562 | +9.89% | |
| National Bank Of Canada | 0.00% | 20,000 | $3,079,700 | $3,384,200 | +$304,500 | +9.89% | |
| State Street Corp | 0.00% | 15,924 | $2,452,057 | $2,694,500 | +$242,443 | +9.89% | |
| Verdad Advisers, Lp | 2.03% | 13,758 | $2,118,526 | $2,327,991 | +$209,465 | +9.89% | |
| Orbimed Advisors Llc | 0.04% | 13,300 | $2,048,001 | $2,250,493 | +$202,492 | +9.89% | |
| Td Asset Management Inc | 0.00% | 13,010 | $2,003,345 | $2,201,422 | +$198,077 | +9.89% | |
| Boothbay Fund Management, Llc | 0.04% | 12,733 | $1,960,691 | $2,154,551 | +$193,860 | +9.89% | |
| Qube Research & Technologies Ltd | 0.00% | 12,171 | $1,874,151 | $2,059,455 | +$185,304 | +9.89% | |
| Lighthouse Investment Partners, Llc | 0.05% | 10,000 | $1,539,850 | $1,692,100 | +$152,250 | +9.89% | |
| Manufacturers Life Insurance Company, The | 0.00% | 9,820 | $1,512,133 | $1,661,642 | +$149,509 | +9.89% | |
| Highvista Strategies Llc | 0.34% | 9,554 | $1,471,173 | $1,616,632 | +$145,459 | +9.89% | |
| Squarepoint Ops Llc | 0.00% | 8,785 | $1,352,758 | $1,486,510 | +$133,752 | +9.89% | |
| Barclays Plc | 0.00% | 6,822 | $1,050,486 | $1,154,351 | +$103,865 | +9.89% | |
| Capricorn Fund Managers Ltd | 0.08% | 6,400 | $985,504 | $1,082,944 | +$97,440 | +9.89% | |
| Voleon Capital Management Lp | 0.02% | 6,289 | $968,412 | $1,064,162 | +$95,750 | +9.89% | |
| Gsa Capital Partners Llp | 0.04% | 4,364 | $672,000 | $738,432 | +$66,432 | +9.89% | |
| Smartharvest Portfolios, Llc | 0.22% | 4,359 | $671,221 | $737,586 | +$66,365 | +9.89% | |
| Xtx Topco Ltd | 0.01% | 4,333 | $667,217 | $733,187 | +$65,970 | +9.89% | |
| Mariner, Llc | 0.00% | 3,835 | $590,533 | $648,920 | +$58,387 | +9.89% |
Frequently asked questions about BLTE
Who owns the most BLTE stock?
The largest holders of BLTE are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for BELITE BIO INC - ADR (BLTE).
Is BLTE widely held by superinvestors?
Many widely followed stocks like BLTE appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly BLTE is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.